SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

DA Davidson Downgrades Medifast to Neutral, Lowers Price Target to $74

DA Davidson downgrades Medifast (NYSE:MED) from Buy to Neutral and lowers the price target from $250 to $74.

Benzinga · -

DA Davidson downgrades Medifast (NYSE:MED) from Buy to Neutral and lowers the price target from $250 to $74.